This suggests, critically, that the mechanism by which wtHTT participates in the expression of pro-inflammatory cytokines is distinct to the pathological gain of function activation of the NFκB pathway that occurs in Huntington’s disease monocytes and macrophages. The gene discussed is NFKB1; the disease is Huntington disease.